These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity. Arroyo JC; Milligan WL; Davis J; Mitchell D South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326 [TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation of the ototoxicity of aminoglycosides. Comparison of tobramycin and gentamycin. Preliminary report]. Fee WE Nouv Presse Med; 1978 Nov; 7(42):3854-5. PubMed ID: 309592 [No Abstract] [Full Text] [Related]
37. Protective effect of fosfomycin against aminoglycoside ototoxicity. Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T ORL J Otorhinolaryngol Relat Spec; 1985; 47(1):42-8. PubMed ID: 3969267 [TBL] [Abstract][Full Text] [Related]
38. Pathogenesis and detection of aminoglycoside ototoxicity. Keene M; Hawke M J Otolaryngol; 1981 Jun; 10(3):228-36. PubMed ID: 7024566 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic initiatives for the avoidance of aminoglycoside toxicity. Whelton A J Clin Pharmacol; 1985 Mar; 25(2):67-81. PubMed ID: 3886711 [TBL] [Abstract][Full Text] [Related]